Holen Sie sich die Stockscreener-App
8.40
4.11%
-0.36
Schlusskurs vom Vortag:
$8.76
Offen:
$8.9
24-Stunden-Volumen:
27,165
Relative Volume:
0.22
Marktkapitalisierung:
$44.27M
Einnahmen:
$7.97M
Nettoeinkommen (Verlust:
$-75.74M
KGV:
-0.3459
EPS:
-24.2853
Netto-Cashflow:
$-85.33M
1W Leistung:
-7.89%
1M Leistung:
+16.50%
6M Leistung:
-64.92%
1J Leistung:
-36.60%
1-Tages-Spanne:
$8.25
$8.98
1-Wochen-Bereich:
$8.25
$9.44
52-Wochen-Spanne:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Firmenname
Aligos Therapeutics Inc
Sektor
Branche
Telefon
(800) 466-6059
Adresse
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Vergleichen Sie ALGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
8.33 | 55.83M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.07 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.78 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.03 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
596.39 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.37 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Herabstufung | Jefferies | Buy → Hold |
| 2021-09-09 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-11-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Eingeleitet | JP Morgan | Overweight |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Aligos Therapeutics Inc Aktie (ALGS) Neueste Nachrichten
What data driven models say about Aligos Therapeutics Inc.’s futureFree Swing Trade With Risk Management - Newser
Volatility clustering patterns for Aligos Therapeutics Inc.High Reward Investment Strategy for Beginners - Newser
Real time breakdown of Aligos Therapeutics Inc. stock performanceFree Weekly Potential Breakout Stock List - Newser
Why Aligos Therapeutics Inc. stock attracts strong analyst attentionIntraday Price Action Forecast Planner - Newser
Is This the Dip to Buy in Aligos Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it
Is Aligos Therapeutics Inc. stock overvalued or undervaluedInvest confidently with expert support - jammulinksnews.com
Statistical indicators supporting Aligos Therapeutics Inc.’s strengthMarket Sentiment Tracker with Smart Alerts - Newser
How does Aligos Therapeutics Inc. generate profit in a changing economyOverwhelming profit margins - jammulinksnews.com
Aligos Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming Predictive Analytics for Equity Growth Potential - Newser
News impact scoring models applied to Aligos Therapeutics Inc. Daily Stock Watch Summary with Key Insights - Newser
What data driven models say about Aligos Therapeutics Inc.’s future Forecast Model for Intraday Buy Signals - Newser
What are the latest earnings results for Aligos Therapeutics Inc.Unlock your portfolio’s hidden potential - jammulinksnews.com
What makes Aligos Therapeutics Inc. stock price move sharplyMaximize portfolio growth with expert advice - jammulinksnews.com
Is Aligos Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsidePro Trader Stock Focus - Newser
Aligos Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Low-Risk Investment Plans - Newser
Moving Average Trends for Aligos Therapeutics Inc. Stock: What They IndicateTrend Based Entry Alerts - Newser
What analysts say about Aligos Therapeutics Inc. stockLightning-fast capital gains - PrintWeekIndia
Will Aligos Therapeutics Inc. stock benefit from AI tech trendsSuperior returns - jammulinksnews.com
Does Aligos Therapeutics Inc. stock pay reliable dividendsFree Stock Market Knowledge Sharing - jammulinksnews.com
What drives Aligos Therapeutics Inc. stock priceMarket-leading profit generation - Autocar Professional
Aligos Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com
Is Aligos Therapeutics Inc. a good long term investmentConsistent high-performance stocks - jammulinksnews.com
How Aligos Therapeutics Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser
Finanzdaten der Aligos Therapeutics Inc-Aktie (ALGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.79%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):